Search
Search Results
-
Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer
Background & aimsTertiary lymphoid structures (TLSs) are predictive biomarkers of favorable clinical outcomes and immunotherapy response in several...
-
A middle lobe sparing sleeve resection versus bilobectomy for right lower central non-small cell lung cancer: a retrospective propensity score matched cohort study
ObjectivesThe right lower sleeve lobectomy is a rarely performed major lung resection.This study aims to evaluate the safety and effectiveness of...
-
Pulmonary wedge resection for lung cancer develo** in a single transplanted lung: a case report
BackgroundPrimary lung cancer arising in a transplanted lung is much rarer than cancer arising in a native lung. We herein describe a case of lung...
-
Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer
ObjectiveThe purpose of this study was to assess 10-year follow-up outcomes after surgical resection in patients with stage IA invasive non-small...
-
The global burden of lung cancer: current status and future trends
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer incidence and mortality rates differ substantially across...
-
Antibody–drug conjugates (ADCs) in lung cancer treatment
ADCs will likely become another important treatment strategy in advanced, pretreated lung cancer where current treatment options are limited. Both...
-
Lung microbiome: an emerging player in lung cancer pathogenesis and progression
The microbiome of the lungs, although until recently neglected, is now emerging as a potential contributor to chronic lung diseases, including...
-
Surgery for lung cancer: insight from a state cancer centre in India
PurposeLung cancer is one of the most common cancers in India. However, less than half receive treatment with a curative intent and very few undergo...
-
Primary lung cancer in children and adolescents
PurposePrimary lung cancer is extremely rare in children and adolescents. The aim of this study is to clarify clinical features and outcomes of...
-
CACA guidelines for holistic integrative management of lung cancer
Lung cancer (LC) is among the malignant tumors with the highest disease burden in the world, accounting for approximately 11.4% of all cancer cases,...
-
Himalayan flora: targeting various molecular pathways in lung cancer
The fatal amplification of lung cancer across the globe and the limitations of current treatment strategies emphasize the necessity for substitute...
-
Geographical Disparities in Lung Cancer in Canada: A Review
Purpose of ReviewThe eastern provinces of Canada exhibit a heightened prevalence and mortality rate of lung cancer compared to their western...
-
Significance of preoperative evaluation of modified advanced lung cancer inflammation index for patients with resectable non-small cell lung cancer
ObjectivesBody composition and systemic inflammation/nutrition have been identified as important clinical factors in cancer patients. The modified...
-
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
IntroductionRecent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the...
-
Lung cancer in patients who have never smoked — an emerging disease
Lung cancer is the most common cause of cancer-related deaths globally. Although smoking-related lung cancers continue to account for the majority of...
-
The role of alternative splicing in lung cancer
Aberrant alternative splicing (AS) events are frequently observed in lung cancer, which can be attributed to aberrant gene AS, alterations in...
-
Thoracic high resolution computed tomography evaluation of imaging abnormalities of 108 lung cancer patients with different pulmonary function
PurposePreserved ratio impaired spirometry (PRISm) and chronic obstructive pulmonary disease (COPD) belong to lung function injury. PRISm is a...
-
Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer
BackgroundCancer stem cells may be the source of cancer-causing mutant cells and are closely related to the prognosis of cancer. Our study aimed to...
-
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies
Central nervous system (CNS) metastases are common in non-small-cell lung cancer (NSCLC) and associated with poor prognosis and high disease burden....
-
Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3
PurposeTargeted therapies have markedly improved the prognosis of lung cancer patients; nevertheless, challenges persist, including limited...
